Cargando…
CD95/Fas protects triple negative breast cancer from anti-tumor activity of NK cells
The apoptosis inducing receptor CD95/Fas has multiple tumorigenic activities. In different genetically engineered mouse models tumor-expressed CD95 was shown to be critical for cell growth. Using a combination of immune-deficient and immune-competent mouse models, we now establish that loss of CD95...
Autores principales: | Qadir, Abdul S., Guégan, Jean Philippe, Ginestier, Christophe, Chaibi, Assia, Bessede, Alban, Charafe-Jauffret, Emmanuelle, Macario, Manon, Lavoué, Vincent, Rouge, Thibault de la Motte, Law, Calvin, Vilker, Jacob, Wang, Hongbin, Stroup, Emily, Schipma, Matthew J., Bridgeman, Bryan, Murmann, Andrea E., Ji, Zhe, Legembre, Patrick, Peter, Marcus E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8593563/ https://www.ncbi.nlm.nih.gov/pubmed/34816102 http://dx.doi.org/10.1016/j.isci.2021.103348 |
Ejemplares similares
-
CD95/Fas suppresses NF-κB activation through recruitment of KPC2 in a CD95L/FasL-independent mechanism
por: Guégan, Jean-Philippe, et al.
Publicado: (2021) -
CD95/Fas, Non-Apoptotic Signaling Pathways, and Kinases
por: Le Gallo, Matthieu, et al.
Publicado: (2017) -
The mechanism of how CD95/Fas activates the Type I IFN/STAT1 axis, driving cancer stemness in breast cancer
por: Qadir, Abdul S., et al.
Publicado: (2020) -
Breast cancer stem cells: tools and models to rely on
por: Charafe-Jauffret, Emmanuelle, et al.
Publicado: (2009) -
Targeting breast cancer stem cells: fishing season open!
por: Ginestier, Christophe, et al.
Publicado: (2010)